ZWJ Investment Counsel’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-47,975
| Closed | -$62.4K | – | 246 |
|
|
2025
Q2 | $62.4K | Hold |
47,975
| – | – | ﹤0.01% | 238 |
|
|
2025
Q1 | $66.7K | Buy |
47,975
+2,700
| +6% | +$5.91K | ﹤0.01% | 207 |
|
|
2024
Q4 | $104K | Hold |
45,275
| – | – | ﹤0.01% | 218 |
|
|
2024
Q3 | $123K | Sell |
45,275
-1,200
| -3% | -$2.93K | 0.01% | 231 |
|
|
2024
Q2 | $109K | Buy |
46,475
+1,300
| +3% | +$4.15K | ﹤0.01% | 220 |
|
|
2024
Q1 | $212K | Hold |
45,175
| – | – | 0.01% | 217 |
|
|
2023
Q4 | $220K | Sell |
45,175
-100
| -0.2% | -$415 | 0.01% | 184 |
|
|
2023
Q3 | $211K | Hold |
45,275
| – | – | 0.01% | 182 |
|
|
2023
Q2 | $335K | Buy |
45,275
+2,025
| +5% | +$13.5K | 0.02% | 151 |
|
|
2023
Q1 | $354K | Buy |
43,250
+1,250
| +3% | +$13.1K | 0.02% | 147 |
|
|
2022
Q4 | $402K | Buy |
42,000
+1,500
| +4% | +$18.5K | 0.02% | 138 |
|
|
2022
Q3 | $476K | Sell |
40,500
-1,500
| -4% | -$19.8K | 0.03% | 125 |
|
|
2022
Q2 | $540K | Buy |
42,000
+22,000
| +110% | +$228K | 0.03% | 126 |
|
|
2022
Q1 | $220K | Buy |
+20,000
| New | +$232K | 0.01% | 163 |
|
ZWJ Investment Counsel's AKYA Position: Q3 2025 in Review
ZWJ Investment Counsel sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 47,975 shares — an estimated $62.4K sold.
ZWJ Investment Counsel first reported a position in AKYA in Q1 2022 and held it in 14 quarters. The position peaked at $540K in Q2 2022. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.
- ZWJ Investment Counsel reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
- ZWJ Investment Counsel sold 47,975 Akoya BioSciences shares in Q3 2025, an estimated $62.4K.
- ZWJ Investment Counsel first reported a position in Akoya BioSciences in Q1 2022 and held it in 14 quarters.
- ZWJ Investment Counsel's Akoya BioSciences position peaked at $540K in Q2 2022.
- 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.
Based on ZWJ Investment Counsel's 13F filing for Q3 2025, filed 15 Oct 2025.